Legal Representation
Attorney
Steven J. Nataupsky
USPTO Deadlines
Next Deadline
456 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-11-03)
Due Date
November 03, 2026
Grace Period Ends
May 03, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
43 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 3, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Oct 1, 2020 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Sep 30, 2020 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Sep 14, 2020 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Sep 14, 2020 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Sep 14, 2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Sep 2, 2020 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Sep 2, 2020 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Sep 2, 2020 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| Sep 2, 2020 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Mar 3, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 7, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 7, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 18, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 4, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Dec 2, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 2, 2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Dec 2, 2019 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Dec 2, 2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Dec 2, 2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Nov 25, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 25, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 25, 2019 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Jul 8, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 24, 2019 | GNSF | O | SUBSEQUENT FINAL EMAILED | Loading... |
| May 24, 2019 | GNS1 | O | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | Loading... |
| May 24, 2019 | CFRC | R | SUBSEQUENT FINAL REFUSAL WRITTEN | Loading... |
| May 7, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 6, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 6, 2019 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Nov 6, 2018 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Nov 6, 2018 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Nov 6, 2018 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Nov 2, 2018 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 1, 2018 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 1, 2018 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 1, 2018 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 1, 2018 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 1, 2018 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 24, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 7, 2018 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Jan 26, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 16, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 010
Medical devices, namely, catheters; Medical devices for the detection, diagnosis, and treatment of strokes, and physical and neuro rehabilitation devices for use with stroke patients
First Use Anywhere:
Nov 2, 2018
First Use in Commerce:
Nov 2, 2018
Classification
International Classes
010
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"CARE"